Stocks and Investing Stocks and Investing
Fri, August 18, 2017
Thu, August 17, 2017

Jason Kolbert Maintained (BCLI) at Strong Buy with Increased Target to $135 on, Aug 17th, 2017


Published on 2024-10-25 22:25:11 - WOPRAI, Jason Kolbert
  Print publication without navigation


Jason Kolbert of Maxim Group, Maintained "Brainstorm Cell Therapeutics Inc." (BCLI) at Strong Buy with Increased Target from $120 to $135 on, Aug 17th, 2017.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources